Am. J. Respir. Crit. Care Med., Volume 156, Number 4, October 1997, 1105-1113

The Systemic Inflammatory Response in the Development of Ventilator-Associated Pneumonia

MARC J. M. BONTEN, ALBERT H. M. FROON, CARLO A. GAILLARD, JAN WILLEM M. GREVE, PETER W. de LEEUW, MARJOLEIN DRENT, ELLEN E. STOBBERINGH, and WIM A. BUURMAN

Departments of Internal Medicine, Surgery, Pulmonology, and Medical Microbiology, University Hospital Maastricht, Maastricht, The Netherlands

Ventilator-associated pneumonia (VAP) is the most frequent occurring infection among mechanically ventilated patients. The clinical presentation of VAP ranges from relatively benign to a severe illness with septic shock. The influence of VAP on patient outcome has not been elucidated and its effects on the inflammatory response of the host are unknown. In a case-control study, the systemic inflammatory response was investigated in patients developing VAP as compared with control patients matched on duration of mechanical ventilation and underlying diseases. Patients developing VAP (n = 42) were matched to a single control (without VAP), who was matched on seven variables. VAP was diagnosed with bronchoscopic techniques. The inflammatory response, reflected by circulating levels of interleukin-6 (IL-6) and interleukin-8 (IL-8), was determined on the day of diagnosis (or day of matching for controls), 4 and 2 d before diagnosis, and 2 d after diagnosis. The development of VAP was not associated with an increase in circulating levels of IL-6 or IL-8. Among patients in which VAP was associated with a clinical presentation of severe sepsis or septic shock (n = 10), IL-6 and IL-8 levels increased and were higher than in the corresponding controls. Moreover, 60% of cases with severe sepsis or septic shock died as compared with 20% of their matched controls (p = 0.06). Mortality rates were similar in patients with uncomplicated VAP and their matched controls (25% and 34%, respectively). High circulating levels of IL-6 and IL-8 were associated with higher mortality rates. The clinical picture of VAP can be subdivided into different types, ranging from uncomplicated to an infection associated with severe sepsis or septic shock, elevated circulating levels of IL-6 and IL-8, and an increased mortality rate.

This article has been cited by other articles:

				R. Menendez and A. Torres Treatment Failure in Community-Acquired Pneumonia Chest, October 1, 2007; 132(4): 1348 - 1355. [Abstract] [Full Text] [PDF]

				M. Koeman, A. J. A. M. van der Ven, E. Hak, H. C. A. Joore, K. Kaasjager, A. G. A. de Smet, G. Ramsay, T. P. J. Dormans, L. P. H. J. Aarts, E. E. de Bel, et al. Oral Decontamination with Chlorhexidine Reduces the Incidence of Ventilator-associated Pneumonia Am. J. Respir. Crit. Care Med., June 15, 2006; 173(12): 1348 - 1355. [Abstract] [Full Text] [PDF]

				C. Brun-Buisson, M. Fartoukh, E. Lechapt, S. Honore, J.-R. Zahar, C. Cerf, and B. Maitre Contribution of Blinded, Protected Quantitative Specimens to the Diagnostic and Therapeutic Management of Ventilator-Associated Pneumonia Chest, August 1, 2005; 128(2): 533 - 544. [Abstract] [Full Text] [PDF]

				C Agusti, A Rano, M Rovira, X Filella, N Benito, A Moreno, and A Torres Inflammatory response associated with pulmonary complications in non-HIV immunocompromised patients Thorax, December 1, 2004; 59(12): 1081 - 1088. [Abstract] [Full Text] [PDF]

				A. H. van Kaam, R. A. Lachmann, E. Herting, A. De Jaegere, F. van Iwaarden, L. A. Noorduyn, J. H. Kok, J. J. Haitsma, and B. Lachmann Reducing Atelectasis Attenuates Bacterial Growth and Translocation in Experimental Pneumonia Am. J. Respir. Crit. Care Med., May 1, 2004; 169(9): 1046 - 1053. [Abstract] [Full Text] [PDF]

				S. Gibot, A. Cravoisy, B. Levy, M.-C. Bene, G. Faure, and P.-E. Bollaert Soluble Triggering Receptor Expressed on Myeloid Cells and the Diagnosis of Pneumonia N. Engl. J. Med., January 29, 2004; 350(5): 451 - 458. [Abstract] [Full Text] [PDF]

				C. Brun-Buisson Antibiotic Therapy of Ventilator-Associated Pneumonia: In Search of the Magic Bullet Chest, March 1, 2003; 123(3): 670 - 673. [Full Text] [PDF]

				P. V. O'Neal, N. Brown, and C. Munro Physiologic Factors Contributing to a Transition in Oral Immunity among Mechanically Ventilated Adults Biol Res Nurs, January 1, 2002; 3(3): 132 - 139. [Abstract] [PDF]

				M. J. M. Bonten, B. J. Kullberg, R. van Dalen, A. R. J. Girbes, I. M. Hoepelman, W. Hustinx, J. W. M. van der Meer, P. Speelman, E. E. Stobberingh, H. A. Verbrugh, et al. Selective digestive decontamination in patients in intensive care J. Antimicrob. Chemother., September 1, 2000; 46(3): 351 - 362. [Abstract] [Full Text] [PDF]

				D. B. MURPHY, N. CREGG, L. TREMBLAY, D. ENGELBERTS, J. G. LAFFEY, A. S. SLUTSKY, A. ROMASCHIN, and B. P. KAVANAGH Adverse Ventilatory Strategy Causes Pulmonary-to-Systemic Translocation of Endotoxin Am. J. Respir. Crit. Care Med., July 1, 2000; 162(1): 27 - 33. [Abstract] [Full Text]

				A. H. M. FROON, M. J. M. BONTEN, C. A. GAILLARD, J. W. M. GREVE, M. A. DENTENER, P. W. de LEEUW, M. DRENT, E. E. STOBBERINGH, and W. A. BUURMAN Prediction of Clinical Severity and Outcome of Ventilator-associated Pneumonia . Comparison of Simplified Acute Physiology Score with Systemic Inflammatory Mediators Am. J. Respir. Crit. Care Med., October 1, 1998; 158(4): 1026 - 1031. [Abstract] [Full Text] [PDF]